Qlife Holding ABOSTO:QLIFE +1.47%15 Quick Ratio is 1.64 as of Mar. 2026, which is 102% above its 10-year median of 0.81. GuruFocus rates OSTO:QLIFE with a GF Score™ of 15/100 and a GF Value™ of kr0.76 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Qlife Holding AB ranks worse than 56.44% on this metric.
Qlife Holding AB has a quick ratio of 1.64. It generally indicates good short-term financial strength.
The historical rank and industry rank for Qlife Holding AB's Quick Ratio or its related term are showing as below:
OSTO:QLIFE'
s Quick Ratio Range Over the Past 10 Years
Min: 0.1 Med: 0.81 Max: 9.15
Current: 1.64
During the past 7 years, Qlife Holding AB's highest Quick Ratio was 9.15. The lowest was 0.10. And the median was 0.81.
OSTO:QLIFE's Quick Ratio is ranked worse than 56.44% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.885
vs OSTO:QLIFE: 1.64
Qlife Holding AB (OSTO:QLIFE) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Qlife Holding AB Quick Ratio Related Terms
Qlife Holding AB Quick Ratio Historical Data
* Premium members only.
The historical data trend for Qlife Holding AB's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:QLIFE vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Qlife Holding AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qlife Holding AB Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Qlife Holding AB's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Qlife Holding AB's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qlife Holding AB (OSTO:QLIFE) has a Quick Ratio of 1.64 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Qlife Holding AB and its competitors. This is 102% above median its historical median of 0.81. Over the past decade, Qlife Holding AB's Quick Ratio has ranged from 0.10 to 9.15. According to the industry distribution chart, Qlife Holding AB ranks #482 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 56.4%.
Is Qlife Holding AB's Quick Ratio too high?
Qlife Holding AB's current Quick Ratio of 1.64 is 102% above median its 10-year median of 0.81. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 9.15. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Qlife Holding AB's value of 1.64 is 13% below this industry median. Based on the distribution chart, Qlife Holding AB ranks #482 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Qlife Holding AB has a GF Score™ of 15/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qlife Holding AB ranks #482 out of 854 companies for Quick Ratio. This places Qlife Holding AB in the lower half of its industry. The industry median Quick Ratio is 1.89. Qlife Holding AB's value of 1.64 is 13% below this benchmark. Historically, Qlife Holding AB's own Quick Ratio has ranged from 0.10 to 9.15 over the past decade. While the company's 10-year median is 0.81 vs. the industry median of 1.89, Qlife Holding AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qlife Holding AB's current Quick Ratio of 1.64 is 13% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Qlife Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qlife Holding AB's current Quick Ratio is 1.64, which is 102% above median its own 10-year median of 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.76, compared to a current price of kr1.93 — trading 153.9% above its estimated fair value. The current Quick Ratio is 1.64, which is 102% above median its 10-year median of 0.81 and 13% below the Medical Devices & Instruments industry median of 1.89. Qlife Holding AB's overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current Quick Ratio is 1.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued.
The current stock price of kr1.93 is trading 153.9% above its estimated GF Value™ of kr0.76.
GuruFocus considers Qlife Holding AB to be Significantly Overvalued.
Key valuation signals for OSTO:QLIFE:
Quick Ratio: 1.64 (102% above median its 10-year median of 0.81)
GF Value™: kr0.76 vs. price of kr1.93 (153.9% above fair value)
Industry Position: 13% below the Medical Devices & Instruments median (#482 of 854)
No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
15GF Score
Get the complete analysis for OSTO:QLIFE
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLIFE has been successfully added to your 
